We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Fast and Simple Picking of Whole Tissue Samples From Storage content piece image
Product News

Fast and Simple Picking of Whole Tissue Samples From Storage

Ziath announce the launch of the Mohawk 48 tube selector and picker. Designed to select and pick wide, heavy, or tall tubes - this new system is perfect for retrieving individual whole tissue samples from storage.
Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration content piece image
Product News

Avacta Announces AVA6000 Receives Orphan Drug Designation From the US Food and Drug Administration

Avacta Group plc announces that the US Food and Drug Administration has granted Orphan Drug Designation to the company’s lead pre|CISION drug candidate, AVA6000, for treatment of soft tissue sarcoma.
Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software To Expand Access to Precision Oncology Biomarker Testing content piece image
Product News

Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software To Expand Access to Precision Oncology Biomarker Testing

To meet the need for rapid genomic insights, Thermo Fisher Scientific has launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.
Indica Labs Announces Collaboration With The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics  content piece image
Product News

Indica Labs Announces Collaboration With The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics

Indica Labs and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) have announced an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.
ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement content piece image
Product News

ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement

ERS Genomics Limited is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD.
OncoBone Ventures Receives HMRC Adcance Assurance for SEIS/EIS content piece image
Product News

OncoBone Ventures Receives HMRC Adcance Assurance for SEIS/EIS

OncoBone Ventures is pleased to announce that it has received Advance Assurance from HMRC that investments in the Company can qualify for tax relief under the Seed Enterprise Investment Scheme (SEIS)/Enterprise Investment Scheme (EIS).
Voltron Therapeutics, Inc. Announces Definitive Proof of Concept Data for its Lead Oncology Candidate content piece image
Product News

Voltron Therapeutics, Inc. Announces Definitive Proof of Concept Data for its Lead Oncology Candidate

Voltron Therapeutics, Inc. has announced that data from the previously announced Study ‘098 demonstrated clear Proof-of Concept for VTX-067 in the treatment of HPV-related cancers.
CN Bio Opens New Laboratory Facilities To Extend Organ-on-a-Chip Contract Research Services Capabilities content piece image
Product News

CN Bio Opens New Laboratory Facilities To Extend Organ-on-a-Chip Contract Research Services Capabilities

CN Bio today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services.
Pre-Clinical Screening Technology Increases Cancer Test Numbers content piece image
Product News

Pre-Clinical Screening Technology Increases Cancer Test Numbers

A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumor sample by up to 50 times.
MaxCyte Signs Strategic Platform License With LG Chem To Advance its Allogeneic CAR-T Programs content piece image
Product News

MaxCyte Signs Strategic Platform License With LG Chem To Advance its Allogeneic CAR-T Programs

MaxCyte, Inc. has announced the signing of a strategic platform license with LG Chem Ltd.
Advertisement